Role of telomeres and telomerase in genomic instability, senescence and cancer

被引:86
作者
Deng, Yibin
Chang, Sandy
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
telomeres; genomic instability; DNA damage; replicative senescence; tumorigenesis;
D O I
10.1038/labinvest.3700673
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Telomeres are ribonucleoprotein structures that protect the end of linear chromosomes from recognition as DNA double-stranded breaks and activation of a DNA damage response. Telomere-associated proteins also regulate telomerase, the protein responsible for maintaining telomere length. Loss of telomere function results from either alteration in the capping function at telomeres, or from progressive loss of telomeric repeats necessary to maintain proper telomeric structure. Dysfunctional telomeres activate p53 to initiate cellular senescence or apoptosis to suppress tumorigenesis. However, in the absence of p53, telomere dysfunction is an important mechanism to generate chromosomal instability commonly found in human carcinomas. Telomerase is expressed in the majority of human cancers, making it an attractive therapeutic target. Emerging anti-telomerase therapies that are currently in clinical trials might prove useful against some forms of human cancers.
引用
收藏
页码:1071 / 1076
页数:6
相关论文
共 50 条
[11]   Mutations of mitotic checkpoint genes in human cancers [J].
Cahill, DP ;
Lengauer, C ;
Yu, J ;
Riggins, GJ ;
Willson, JKV ;
Markowitz, SD ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1998, 392 (6673) :300-303
[12]   Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors [J].
Campisi, J .
CELL, 2005, 120 (04) :513-522
[13]   Telomerase-based immunotherapy of cancer [J].
Carpenter, Erica L. ;
Vonderheide, Robert H. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (10) :1031-1039
[14]   Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression [J].
Chang, S ;
Khoo, CM ;
Naylor, ML ;
Maser, RS ;
DePinho, RA .
GENES & DEVELOPMENT, 2003, 17 (01) :88-100
[15]   In situ analyses of genome instability in breast cancer [J].
Chin, K ;
de Solorzano, CO ;
Knowles, D ;
Jones, A ;
Chou, W ;
Rodriguez, EG ;
Kuo, WL ;
Ljung, BM ;
Chew, K ;
Myambo, K ;
Miranda, M ;
Krig, S ;
Garbe, J ;
Stampfer, M ;
Yaswen, P ;
Gray, JW ;
Lockett, SJ .
NATURE GENETICS, 2004, 36 (09) :984-988
[16]   p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis [J].
Chin, L ;
Artandi, SE ;
Shen, Q ;
Tam, A ;
Lee, SL ;
Gottlieb, GJ ;
Greider, CW ;
DePinho, RA .
CELL, 1999, 97 (04) :527-538
[17]   Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence [J].
Cosme-Blanco, Wilfredo ;
Shen, Mei-Feng ;
Lazar, Alexander J. F. ;
Pathak, Sen ;
Lozano, Guillermina ;
Multani, Asha S. ;
Chang, Sandy .
EMBO REPORTS, 2007, 8 (05) :497-503
[18]   TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY [J].
COUNTER, CM ;
AVILION, AA ;
LEFEUVRE, CE ;
STEWART, NG ;
GREIDER, CW ;
HARLEY, CB ;
BACCHETTI, S .
EMBO JOURNAL, 1992, 11 (05) :1921-1929
[19]   Shelterin: the protein complex that shapes and safeguards human telomeres [J].
de Lange, T .
GENES & DEVELOPMENT, 2005, 19 (18) :2100-2110
[20]   In vivo inhibition of lung cancer by GRN163L:: A novel human telomerase inhibitor [J].
Dikmen, ZG ;
Gellert, GC ;
Jackson, S ;
Gryaznov, S ;
Tressler, R ;
Dogan, P ;
Wright, WE ;
Shay, JW .
CANCER RESEARCH, 2005, 65 (17) :7866-7873